AAX to attend Bio-Japan in Yokohama, Japan

AAX Biotech is excited to attend Bio-Japan in person in Yokohama, Japan (October 9-11)! We will be represented by our CEO, Maria Lisa Knudsen, and are eager to connect with pharma and biotech companies to explore potential collaborations using our proprietary technologies, Seqitope and Opti-mAb.

Our team is on the lookout for new partnerships that can drive forward next-generation antibody therapeutics. If you’re attending Bio-Japan and interested in discussing how we can work together, please reach out to us!

Let’s shape the future of biotech together!🌟